MENU
+Compare
LVTX
Stock ticker: NASDAQ
AS OF
Apr 2, 04:59 PM (EDT)
Price
$1.28
Change
+$0.03 (+2.40%)
Capitalization
33.41M

LVTX LAVA Therapeutics NV Forecast, Technical & Fundamental Analysis

LAVA Therapeutics NV is a biotechnology company... Show more

LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for LVTX with price predictions
Apr 01, 2025

LVTX in upward trend: 10-day moving average broke above 50-day moving average on February 26, 2025

The 10-day moving average for LVTX crossed bullishly above the 50-day moving average on February 26, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 64 cases where LVTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

LVTX moved above its 50-day moving average on February 25, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LVTX advanced for three days, in of 169 cases, the price rose further within the following month. The odds of a continued upward trend are .

LVTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 61 cases where LVTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for LVTX moved out of overbought territory on March 10, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 18 similar instances where the indicator moved out of overbought territory. In of the 18 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on March 20, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on LVTX as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for LVTX turned negative on March 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LVTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.185) is normal, around the industry mean (13.458). P/E Ratio (0.000) is within average values for comparable stocks, (64.587). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.867). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (2.800) is also within normal values, averaging (251.391).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LVTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LVTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
LVTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

LVTX is expected to report earnings to rise 126.21% to -31 cents per share on May 14

LAVA Therapeutics NV LVTX Stock Earnings Reports
Q1'25
Est.
$-0.32
Q4'24
Beat
by $0.16
Q3'24
Missed
by $0.13
Q2'24
Beat
by $0.02
Q1'24
Beat
by $0.29
The last earnings report on March 28 showed earnings per share of -14 cents, beating the estimate of -30 cents. With 6.44K shares outstanding, the current market capitalization sits at 33.41M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Yalelaan 62
Phone
+31 850163100
Employees
35
Web
https://www.lavatherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDVT38.781.19
+3.17%
Red Violet
COEP9.470.10
+1.07%
Coeptis Therapeutics Holdings Inc
SLM29.620.25
+0.85%
SLM Corp
TAK14.900.03
+0.20%
Takeda Pharmaceutical Company Limited
NRP102.75-1.15
-1.11%
Natural Resource Partners LP

LVTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, LVTX has been loosely correlated with BDRX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if LVTX jumps, then BDRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LVTX
1D Price
Change %
LVTX100%
-1.57%
BDRX - LVTX
41%
Loosely correlated
-9.09%
ONVO - LVTX
34%
Loosely correlated
-0.45%
TCRX - LVTX
34%
Loosely correlated
-7.97%
CYDY - LVTX
31%
Poorly correlated
+7.15%
PCSA - LVTX
27%
Poorly correlated
+11.35%
More